Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Expectoration | Research

Diagnostic stewardship aiming at expectorated or induced sputum promotes microbial diagnosis in community-acquired pneumonia

Authors: Bjørn Waagsbø, Eva Margrethe Buset, Jørn-Åge Longva, Merete Bjerke, Birgitte Bakkene, Anne-Stine Ertesvåg, Hanne Holmen, Marko Nikodojevic, To Thy Tran, Andreas Christensen, Einar Nilsen, Jan Kristian Damås, Lars Heggelund

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Purpose

Studies on aetiology of community-acquired pneumonia (CAP) vary in terms of microbial sampling methods, anatomical locations, and laboratory analyses, since no gold standard exists. In this large, multicentre, retrospective, regional study from Norway, our primary objective was to report the results of a strategic diagnostic stewardship intervention, targeting diagnostic yield from lower respiratory tract sampling. The secondary objective was to report hospitalized CAP aetiology and the diagnostic yield of various anatomical sampling locations.

Methods

Medical records from cases diagnosed with hospitalized CAP were collected retrospectively from March throughout May for three consecutive years at six hospitals. Between year one and two, we launched a diagnostic stewardship intervention at the emergency room level for the university teaching hospital only. The intervention was multifaceted aiming at upscaling specimen collection and enhancing collection techniques. Year one at the interventional hospital and every year at the five other emergency hospitals were used for comparison.

Results

Of the 1280 included cases of hospitalized CAP, a microbiological diagnosis was established for 29.1% among 1128 blood cultures and 1444 respiratory tract specimens. Blood cultures were positive for a pathogenic respiratory tract microbe in 4.9% of samples, whereas upper and lower respiratory tract samples overall provided a probable microbiological diagnosis in 21.3% and 47.5%, respectively. Expectorated or induced sputum overall provided aetiology in 51.7% of the samples. At the interventional hospital, the number of expectorated or induced sputum samples were significantly increased, and diagnostic yield from expectorated or induced sputum was significantly enhanced from 41.2 to 62.0% after the intervention (p = 0.049). There was an over-representation of samples from the interventional hospital during the study period. Non-typeable Haemophilus influenza and Streptococcus pneumoniae accounted for 25.3% and 24.7% of microbiologically confirmed cases, respectively.

Conclusion

Expectorated or induced sputum outperformed other sampling methods in providing a reliable microbiological diagnosis for hospitalized CAP. A diagnostic stewardship intervention significantly improved diagnostic yield of lower respiratory tract sampling.
Appendix
Available only for authorised users
Literature
1.
go back to reference Musher DM, Thorner AR. Community-acquired pneumonia. N Engl J Med. 2014;371(17):1619–28.CrossRef Musher DM, Thorner AR. Community-acquired pneumonia. N Engl J Med. 2014;371(17):1619–28.CrossRef
2.
go back to reference Faner R, et al. The microbiome in respiratory medicine: current challenges and future perspectives. Eur Respir J. 2017;49(4):1602086.CrossRef Faner R, et al. The microbiome in respiratory medicine: current challenges and future perspectives. Eur Respir J. 2017;49(4):1602086.CrossRef
3.
go back to reference Fally M et al. The increasing importance of Haemophilus influenzae in community-acquired pneumonia: results from a Danish cohort study. Infect Dis (Lond), 2020: 1–9. Fally M et al. The increasing importance of Haemophilus influenzae in community-acquired pneumonia: results from a Danish cohort study. Infect Dis (Lond), 2020: 1–9.
4.
go back to reference Wootton DG, et al. A Haemophilus sp. dominates the microbiota of sputum from UK adults with non-severe community acquired pneumonia and chronic lung disease. Sci Rep. 2019;9(1):2388.CrossRef Wootton DG, et al. A Haemophilus sp. dominates the microbiota of sputum from UK adults with non-severe community acquired pneumonia and chronic lung disease. Sci Rep. 2019;9(1):2388.CrossRef
5.
go back to reference Bartlett JG. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis. 2011;52(Suppl 4):S296-304.CrossRef Bartlett JG. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis. 2011;52(Suppl 4):S296-304.CrossRef
6.
go back to reference Egelund GB, et al. Penicillin treatment for patients with Community-Acquired Pneumonia in Denmark: a retrospective cohort study. BMC Pulm Med. 2017;17(1):66.CrossRef Egelund GB, et al. Penicillin treatment for patients with Community-Acquired Pneumonia in Denmark: a retrospective cohort study. BMC Pulm Med. 2017;17(1):66.CrossRef
7.
go back to reference Athlin S, et al. Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017. Infect Dis (Lond). 2018;50(4):247–72.CrossRef Athlin S, et al. Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017. Infect Dis (Lond). 2018;50(4):247–72.CrossRef
8.
go back to reference Johansson N, Kalin M, Hedlund J. Clinical impact of combined viral and bacterial infection in patients with community-acquired pneumonia. Scand J Infect Dis. 2011;43(8):609–15.CrossRef Johansson N, Kalin M, Hedlund J. Clinical impact of combined viral and bacterial infection in patients with community-acquired pneumonia. Scand J Infect Dis. 2011;43(8):609–15.CrossRef
9.
go back to reference Holter JC, et al. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis. 2015;15:64.CrossRef Holter JC, et al. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis. 2015;15:64.CrossRef
10.
go back to reference Weiszhar Z, Horvath I. Induced sputum analysis: step by step. Breath. 2013;9(4):301–5.CrossRef Weiszhar Z, Horvath I. Induced sputum analysis: step by step. Breath. 2013;9(4):301–5.CrossRef
11.
go back to reference Murray PR, EJ Baron, JH Jorgenson, Pfaller MA, Yolken RH eds. Manual of clinical microbiology 8th edition. 8th edn., ed. A. Balows. ASM Press: American Society of Microbiology. 2003. Murray PR, EJ Baron, JH Jorgenson, Pfaller MA, Yolken RH eds. Manual of clinical microbiology 8th edition. 8th edn., ed. A. Balows. ASM Press: American Society of Microbiology. 2003.
12.
go back to reference Jain S, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015;373(5):415–27.CrossRef Jain S, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015;373(5):415–27.CrossRef
13.
go back to reference Torres A, et al. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis. 2014;33(7):1065–79.CrossRef Torres A, et al. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis. 2014;33(7):1065–79.CrossRef
14.
go back to reference Roysted W, et al. Aetiology and risk factors of community-acquired pneumonia in hospitalized patients in Norway. Clin Respir J. 2016;10(6):756–64.CrossRef Roysted W, et al. Aetiology and risk factors of community-acquired pneumonia in hospitalized patients in Norway. Clin Respir J. 2016;10(6):756–64.CrossRef
15.
go back to reference Stralin K. Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia. Int J Antimicrob Agents. 2008;31(1):3–11.CrossRef Stralin K. Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia. Int J Antimicrob Agents. 2008;31(1):3–11.CrossRef
17.
go back to reference Neill AM, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax. 1996;51(10):1010–6.CrossRef Neill AM, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax. 1996;51(10):1010–6.CrossRef
18.
go back to reference Anevlavis S, et al. A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J Infect. 2009;59(2):83–9.CrossRef Anevlavis S, et al. A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J Infect. 2009;59(2):83–9.CrossRef
19.
go back to reference Braeken DCW, et al. Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade. Infection. 2021;49:533.CrossRef Braeken DCW, et al. Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade. Infection. 2021;49:533.CrossRef
20.
go back to reference Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon? Proc Am Thorac Soc. 2004;1(2):109–14.CrossRef Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon? Proc Am Thorac Soc. 2004;1(2):109–14.CrossRef
21.
go back to reference Cleary D et al. Pneumococcal vaccine impacts on the population genomics of non-typeable Haemophilus influenzae. Microb Genom. 2018; 4(9). Cleary D et al. Pneumococcal vaccine impacts on the population genomics of non-typeable Haemophilus influenzae. Microb Genom. 2018; 4(9).
22.
go back to reference Metlay JP, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–67.CrossRef Metlay JP, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–67.CrossRef
23.
go back to reference Hanson KE, et al. Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA’s Diagnostics Committee. Clin Infect Dis. 2020;71:2744.CrossRef Hanson KE, et al. Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA’s Diagnostics Committee. Clin Infect Dis. 2020;71:2744.CrossRef
24.
go back to reference Quah J, et al. Impact of microbial Aetiology on mortality in severe community-acquired pneumonia. BMC Infect Dis. 2018;18(1):451.CrossRef Quah J, et al. Impact of microbial Aetiology on mortality in severe community-acquired pneumonia. BMC Infect Dis. 2018;18(1):451.CrossRef
25.
go back to reference Roger PM, et al. Risk factors for unnecessary antibiotic therapy: a major role for clinical management. Clin Infect Dis. 2019;69(3):466–72.CrossRef Roger PM, et al. Risk factors for unnecessary antibiotic therapy: a major role for clinical management. Clin Infect Dis. 2019;69(3):466–72.CrossRef
26.
go back to reference Braykov NP, et al. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect Dis. 2014;14(12):1220–7.CrossRef Braykov NP, et al. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect Dis. 2014;14(12):1220–7.CrossRef
27.
go back to reference van Rijn AL, et al. Clinical implications of rapid ePlex(R) Respiratory Pathogen Panel testing compared to laboratory-developed real-time PCR. Eur J Clin Microbiol Infect Dis. 2018;37(3):571–7.CrossRef van Rijn AL, et al. Clinical implications of rapid ePlex(R) Respiratory Pathogen Panel testing compared to laboratory-developed real-time PCR. Eur J Clin Microbiol Infect Dis. 2018;37(3):571–7.CrossRef
28.
go back to reference Wabe N et al. Impact of rapid molecular diagnostic testing of respiratory viruses on outcomes of adults hospitalized with respiratory illness: a multicenter quasi-experimental study. J Clin Microbiol. 2019; 57(4). Wabe N et al. Impact of rapid molecular diagnostic testing of respiratory viruses on outcomes of adults hospitalized with respiratory illness: a multicenter quasi-experimental study. J Clin Microbiol. 2019; 57(4).
29.
go back to reference Mandell LA, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27-72.CrossRef Mandell LA, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27-72.CrossRef
30.
go back to reference Ogawa H, et al. Sputum gram stain for bacterial pathogen diagnosis in community-acquired pneumonia: a systematic review and Bayesian meta-analysis of diagnostic accuracy and yield. Clin Infect Dis. 2020;71(3):499–513.CrossRef Ogawa H, et al. Sputum gram stain for bacterial pathogen diagnosis in community-acquired pneumonia: a systematic review and Bayesian meta-analysis of diagnostic accuracy and yield. Clin Infect Dis. 2020;71(3):499–513.CrossRef
31.
go back to reference Cassini A, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.CrossRef Cassini A, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.CrossRef
32.
go back to reference Barlam TF, et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis. 2016;62(10):e51-77.CrossRef Barlam TF, et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis. 2016;62(10):e51-77.CrossRef
33.
go back to reference Lydon EC, et al. Validation of a host response test to distinguish bacterial and viral respiratory infection. EBioMedicine. 2019;48:453–61.CrossRef Lydon EC, et al. Validation of a host response test to distinguish bacterial and viral respiratory infection. EBioMedicine. 2019;48:453–61.CrossRef
Metadata
Title
Diagnostic stewardship aiming at expectorated or induced sputum promotes microbial diagnosis in community-acquired pneumonia
Authors
Bjørn Waagsbø
Eva Margrethe Buset
Jørn-Åge Longva
Merete Bjerke
Birgitte Bakkene
Anne-Stine Ertesvåg
Hanne Holmen
Marko Nikodojevic
To Thy Tran
Andreas Christensen
Einar Nilsen
Jan Kristian Damås
Lars Heggelund
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07199-4

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue